Get started
Hester Biosciences LimitedHester Biosciences LimitedHester Biosciences Limited

Hester Biosciences Limited

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.96 B‬ INR
Dividend yield (indicated)
0.43%
Price to earnings Ratio (TTM)
37.15
Basic EPS (TTM)
51.55 INR
Net income (FY)
‪274.88 M‬ INR
Revenue (FY)
‪3.11 B‬ INR
Shares float
‪3.18 M‬
Beta (1Y)
0.19

Employees


Employees (FY)
850
Change (1Y)
−150 −15.00%
Revenue / Employee (1Y)
‪3.66 M‬ INR
Net income / Employee (1Y)
‪323.39 K‬ INR

About Hester Biosciences Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Rajiv Dinesh Gandhi
Website
hester.in
Headquarters
Ahmedabad
Founded
1987
ISIN
INE782E01017
FIGI
BBG000DP7S55
Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. It operates through the following segments: Poultry Healthcare and Animal Healthcare. The Poultry Healthcare segment offers vaccines and health products for poultry animals. The Animal Healthcare segment provides vaccines and health products including, dugs, feed supplements, and disinfectants for large animals. The company was founded by Rajiv Dinesh Gandhi on April 29, 1987 and is headquartered in Ahmedabad, India.

Check out other big names from the same industry as HESTERBIO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


MOHEALTH
Motilal Oswal S&P BSE Healthcare ETF
Weight
0.04%
Market value
‪1.79 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of HESTERBIO is 1,710.15 INR — it has increased by 3.10% in the past 24 hours. Watch Hester Biosciences Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Hester Biosciences Limited stocks are traded under the ticker HESTERBIO.
HESTERBIO stock has risen by 3.47% compared to the previous week, the month change is a −1.19% fall, over the last year Hester Biosciences Limited has showed a −35.42% decrease.
HESTERBIO reached its all-time high on Jul 26, 2024 with the price of 3,375.45 INR, and its all-time low was 4.65 INR and was reached on Nov 11, 2003. View more price dynamics on HESTERBIO chart.
See other stocks reaching their highest and lowest prices.
HESTERBIO stock is 3.49% volatile and has beta coefficient of 0.19. Track Hester Biosciences Limited stock price on the chart and check out the list of the most volatile stocks — is Hester Biosciences Limited there?
Today Hester Biosciences Limited has the market capitalization of ‪14.39 B‬, it has increased by 3.06% over the last week.
Yes, you can track Hester Biosciences Limited financials in yearly and quarterly reports right on TradingView.
Hester Biosciences Limited is going to release the next earnings report on Feb 14, 2026. Keep track of upcoming events with our Earnings Calendar.
HESTERBIO net income for the last quarter is ‪144.49 M‬ INR, while the quarter before that showed ‪164.42 M‬ INR of net income which accounts for −12.12% change. Track more Hester Biosciences Limited financial stats to get the full picture.
Yes, HESTERBIO dividends are paid annually. The last dividend per share was 7.00 INR. As of today, Dividend Yield (TTM)% is 0.41%. Tracking Hester Biosciences Limited dividends might help you take more informed decisions.
Hester Biosciences Limited dividend yield was 0.56% in 2024, and payout ratio reached 21.66%. The year before the numbers were 0.43% and 27.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 13, 2025, the company has 850 employees. See our rating of the largest employees — is Hester Biosciences Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hester Biosciences Limited EBITDA is ‪587.74 M‬ INR, and current EBITDA margin is 20.04%. See more stats in Hester Biosciences Limited financial statements.
Like other stocks, HESTERBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hester Biosciences Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hester Biosciences Limited technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hester Biosciences Limited stock shows the sell signal. See more of Hester Biosciences Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.